100 related articles for article (PubMed ID: 25972319)
1. KRAS Mutations in Mucinous Lesions of the Uterus.
He M; Jackson CL; Gubrod RB; Breese V; Steinhoff M; Lawrence WD; Xiong J
Am J Clin Pathol; 2015 Jun; 143(6):778-84. PubMed ID: 25972319
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations.
Hong W; Abi-Raad R; Alomari AK; Hui P; Buza N
Hum Pathol; 2015 Jul; 46(7):1000-5. PubMed ID: 25997988
[TBL] [Abstract][Full Text] [Related]
3. Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium.
Alomari A; Abi-Raad R; Buza N; Hui P
Mod Pathol; 2014 May; 27(5):675-80. PubMed ID: 24186144
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Characteristics and
Sung JY; Jung YY; Kim HS
Anticancer Res; 2018 May; 38(5):2779-2786. PubMed ID: 29715099
[TBL] [Abstract][Full Text] [Related]
5. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
Zheng XZ; Zhan Y; Ma JH; Xu HW; Zhi WX; Chen TB; Qin XY; Wang P; Zhang LH; Gu YC; Jin YL; Zhu L; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):687-690. PubMed ID: 30220122
[No Abstract] [Full Text] [Related]
6. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma.
Yoo SH; Park BH; Choi J; Yoo J; Lee SW; Kim YM; Kim KR
Mod Pathol; 2012 Nov; 25(11):1496-507. PubMed ID: 22766790
[TBL] [Abstract][Full Text] [Related]
7. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between KRAS mutations and clinicopathologic features in colorectal carcinomas].
Gao J; Zhang J; Lu T; Li XY; Jia N; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):595-8. PubMed ID: 23157826
[TBL] [Abstract][Full Text] [Related]
9. Endometrial carcinomas with significant mucinous differentiation associated with higher frequency of k-ras mutations: a morphologic and molecular correlation study.
Xiong J; He M; Jackson C; Ou JJ; Sung CJ; Breese V; Steinhoff MM; Quddus MR; Tejada-Berges T; Lawrence WD
Int J Gynecol Cancer; 2013 Sep; 23(7):1231-6. PubMed ID: 23851676
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma.
Xiong J; He M; Hansen K; Jackson CL; Breese V; Quddus MR; Sung CJ; Lomme MM; Lawrence WD
Gynecol Oncol; 2016 Jul; 142(1):163-168. PubMed ID: 27154241
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
12. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
13. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in oncogene mutations detected in early-stage low-grade endometrial cancers.
Cote ML; Atikukke G; Ruterbusch JJ; Olson SH; Sealy-Jefferson S; Rybicki BA; Alford SH; Elshaikh MA; Gaba AR; Schultz D; Haddad R; Munkarah AR; Ali-Fehmi R
Int J Gynecol Cancer; 2012 Oct; 22(8):1367-72. PubMed ID: 23013731
[TBL] [Abstract][Full Text] [Related]
15. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
16. Endometrial Adenocarcinomas With Significant Mucinous Differentiation: A Characterization of Intratumoral Heterogeneity of KRAS Mutations in Mucinous and Endometrioid Histologic Components.
Jackson CL; Hang S; Hansen K; He M; Sung CJ; Quddus MR; Xiong M; Wang Y; Patel NR; Lawrence WD; Xiong J
Int J Gynecol Cancer; 2018 Feb; 28(2):241-247. PubMed ID: 29303928
[TBL] [Abstract][Full Text] [Related]
17. KRAS mutation positive mucinous adenocarcinoma originating in mature ovarian teratoma: case report and review of literature.
Hershkovitz D; Vlodavsky E; Simon E; Ben-Izhak O
Pathol Int; 2013 Dec; 63(12):611-4. PubMed ID: 24422958
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M
Folia Histochem Cytobiol; 2009; 47(1):65-8. PubMed ID: 19419940
[TBL] [Abstract][Full Text] [Related]
19. LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinoma.
Osoegawa A; Kometani T; Nosaki K; Ondo K; Hamatake M; Hirai F; Seto T; Sugio K; Ichinose Y
Jpn J Clin Oncol; 2011 Sep; 41(9):1132-7. PubMed ID: 21816872
[TBL] [Abstract][Full Text] [Related]
20. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
